Donoghue Forlines LLC Organon & Co. Transaction History

Donoghue Forlines LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$31.66 - $38.9 $88,996 - $109,347	-2,811 Reduced 13.19%	18,498 $624,000
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $175,452 - $226,792	5,762 Added 37.06%	21,309 $744,000
Q4 2021 Feb 11, 2022	BUY	$28.67 - $37.13 $445,732 - $577,260	15,547 New	15,547 $473,000

809

207M

1.19M

910K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

Stay updated on Donoghue Forlines LLC with notifications on news.